Frequent Expression of the Vascular Endothelial Growth Factor in Human Non-small-cell Lung Cancers

Japanese Journal of Clinical Oncology

Volumn 28, Issue 3, 1998, Pages 176-181

  Takahama, Makoto ^a   Tsutsumi, Masahiro ^a   Tsujiuchi, Toshifumi ^a   Kido, Akira ^a   Okajima, Eijiro ^a   Nezu, Kunimoto ^a   Tojo, Takashi ^a   Kushibe, Keiji ^a   Kitamura, Soichiro ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Non small cell lung cancers; Northern blotting; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER STAGING; COLON TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; RECTUM TUMOR; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOKINES; MALE; NEOPLASM STAGING; RECTAL NEOPLASMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032011958     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/28.3.176     Document Type: Article

References (34)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award Lecture. Cancer Res 1986;46:467-73.
2. Le Querrec A, Duval D, Tobelem G. Tumor angiogenesis. Baillieres Clin Haematol 1993;6:711-30.
3. Liotta L, Kleinerman J. Saldel G. Quantitative relationship of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
4. Klagsbrun M, D'Amore PA. Regulation of angiogenesis. Annu Rev Plysiol 1991;53:217-39.
5. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley P, Liotta LA, Israel M, editors. The Molecular Basis of Cancer. Philadelphia: W.B. Saunders, 1995;206-32.
6. Waltenberger J, Claesso-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and FLT1, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269:26988-95.
7. Goldfarb M. The fibroblast growth factor family. Cell Growth Differ 1990;1:439-45.
8. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
9. Ferrara N The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat 1995;36:127-37.
10. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene 1990;8:519-24.
11. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995;129:895-8.
12. Ellis LM, Liu W. Vascular endothelial growth factor (VEGF) expression and alternate splicing in non-metastatic and metastatic human colon tumor cell lines. Proc Am Assoc Cancer Res 1995;36:88.
13. Bosari S, Lee AKC, Dlellis RA, Wiley BD, Heatly GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-61.
14. Guidi AJ, Fischer L, Harris JR, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ of the breast J Natl Cancer Inst 1994;86:614-19.
15. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor and other angiogenic factors in human breast cancer. Cancer Res 1996;56:2013-16.
16. Weinder N, Carroll PR, Flax J, Blumenfeld W, Folkman J Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 1993;145:401-9.
17. Takahashi T, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
18. Ellis LM, Atha T, Cai S. Angiogenic factor expression in primary and metastatic human colorectal cancers. Proc Am Assoc Cancer Res 1994;35:67.
19. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau E., Senger DR, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993;53:4727-35.
20. Chodak GW, Haudenschild C, Gittes RF, Folkman J. Angiogenic activity as a marker of neoplasia and preneoplasia in lesions of the human bladder. Ann Surg 1980;192:762-71.
21. Smith-McCune KK. Weidner N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 1994;54:800-4.
22. Berger DP, Herbstritt L, Dengler WA, Marme D, Mertelsmann R, Fiebig HH. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies. Ann Oncol 1995;6:817-25.
23. Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VHGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 1995;95:1798-807.
24. Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, et al. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 1996;2:1411-16
25. The Japan Lung Cancer Society. General Rules for Clinical and Pathological Recording of Lung Cancer. 4th ed. Tokyo: Kanehara, 1995 (in Japanese).
26. Honoki K, Tsutsumi M, Miyauchi Y, Mu Y, Tsujiuchi T, Morishita T, et al. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-iransplantable osteosarcoma. Cancer Res 1993;53:5038-42.
27. Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM., Galli SJ, et al. Induction of fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 1979;122:166-74.
28. Senger DR, Galli SJ, Dvorak AM. Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid Science 1983;219:983-5.
29. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculostellate cells Proc Natl Acad Sci USA 1989;86:7311-15.
30. Rak J, Mitsuhashi Y, Bayko L. Filmus J, Shirasawa S, Sasazuki T, et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995;55:4575-80.
31. Rodenhuis S, Slebos RJC. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992;52:2665s-9s.
32. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zangwijk N, Bos JL. Mutational activation of the Ki-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 1987;317:929-35.
33. Salven P, Maenpaa H, Orpana A, Alitalo K, Joensuu H Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 1997;3:647-51.
34. Yuan F, Dellian M, Nina S, Ferrara N, Jain RK. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 1996;93:14765-70